By Fineline Cube 
China-based Huadong Medicine Co., Ltd (SHE: 000963) announced that the National Medical Products Administration (NMPA) has accepted a market filing for it’s subsidiary Viora Ltd.’s V30 optical radiofrequency therapy device. The Category III medical device is used for various medical aesthetics procedures, including skin tightening, hair removal, and treating vascular and pigmentation disorders.
Device Overview
The V30 is a multi-functional operation platform that integrates radio frequency (RF), intense pulsed light (IPL), and Nd: YAG laser energy sources. It provides comprehensive solutions for facial and body problems across different populations and skin types. The device is equipped with multiple controllers to enhance treatment flexibility and precision.
Regulatory and Market Status
The V30 is registered in the US and European Union. Its predecessor, the V20 (trade name: Renotion), received NMPA approval in September of last year.-Fineline Info & Tech